Abarca Health, Biogen ally on multiple sclerosis coverage
July 28, 2017
Abarca Health, a pharmacy benefit management and technology company that serves more than 2 million people across the U.S., has signed a value-based reimbursement contract with Biogen Inc. for select products in its multiple sclerosis portfolio.
chat_bubble0 Comment
visibility1986 Views
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA